SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-007072
Filing Date
2024-05-07
Accepted
2024-05-07 16:30:55
Documents
48
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20240331x10q.htm   iXBRL 10-Q 721181
2 EX-31.1 tmb-20240331xex31d1.htm EX-31.1 16119
3 EX-31.2 tmb-20240331xex31d2.htm EX-31.2 16127
4 EX-32.1 tmb-20240331xex32d1.htm EX-32.1 8275
5 EX-32.2 tmb-20240331xex32d2.htm EX-32.2 8837
  Complete submission text file 0001558370-24-007072.txt   3177862

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20240331.xsd EX-101.SCH 22836
7 EX-101.CAL tmb-20240331_cal.xml EX-101.CAL 17829
8 EX-101.DEF tmb-20240331_def.xml EX-101.DEF 90188
9 EX-101.LAB tmb-20240331_lab.xml EX-101.LAB 218752
10 EX-101.PRE tmb-20240331_pre.xml EX-101.PRE 172445
52 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20240331x10q_htm.xml XML 390957
Mailing Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024
Business Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024 360-837-7232
Nuvectis Pharma, Inc. (Filer) CIK: 0001875558 (see all company filings)

IRS No.: 862405608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41264 | Film No.: 24922510
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)